Medications
Risks/Safety of Psychotropic Medication Use During Pregnancy; by Adrienne Einarson; Canadian Journal of Clinical Pharmacology Vol 16 No 1; 2009Adverse Effects in Neonates Exposed to SSRIs and SNRI in Late Gestation; by Gideon Koren and Nina Boucher; Canadian Journal of Clinical Pharmacology Vol 16 No 1; 2009“You've Got Drugs!" V: Prescription Drug Pushers on the Internet; A CASA White Paper; July 2008Risk and Benefit of Drug Use During Pregnancy; by Ferenc Bánhidy, R.Brian Lowry & Andrew E. Czeizel; International Journal of Medical Sciences; Vol 2 No 3 2005Also appears under International
The Use Of Psychotropic Medications In Pregnancy And Lactation; by Kristin Sivertz, Xanthoula Kostaras,; BC Medical Journal (BCMJ); April 2005Also appears under Alcohol, Women and Pregnancy - Breast Feeding
Psychotropic Medication Utilization Parameters for Foster Children; Texas Department of State Health Services; 2004Psychotherapeutic Medications - What Every Counselor Should Know; by Mid-America Addiction Technology Transfer Center (ATTC); 2004Nasmhpd Medical Directors' Technical Report On Psychiatric Polypharmacy; National Association of State Mental Health Program Directors (NASMHPD); September 2001Structural Effects and Neurofunctional Sequelae of Developmental Exposure to Psychotherapeutic Drugs: Experimental and Clinical Aspects; by L. G. Costa, L. Steardo, and V. Cuomo; Pharmacological Reviews, Vol. 56,, 2004Prenatal and Perinatal Effects of Psychotropic Drugs on Neuro-cognitive Development in the Fetus; by Eduard Bercovici; Journal of Developmental Disabilities, Vol 11 No 2Also appears under Brain
Methylphenidate Restores Ventral Tegmental Area Dopamine Neuron Activity in Prenatal Ethanol-Exposed Rats by Augmenting Dopamine Neurotransmission; by K.-C. Choong and R.-Y. Shen; Journal of Pharmacology and Experimental Therapeutics Vol 309 No 2; 2004Reviewer Guidance - Evaluating the Risks of Drug Exposure in Human Pregnancies; US Department of Health and Human Services Food and Drug Administration; 2005A Participant's Guide to Mental Health Clinical Research; National Institute of Mental Health; National Institute of Mental Health, 2000Drugs that Prolong the QT Interval and/or Induce Torsades de Pointes; Raymond Woosley, MD. PhD, University of Arizona Health Sciences Center; 2002Off Label Indications for Atypical Antipsychotics: A systematic Review; Annals of General Hospital Psychiatry, Vol 3 No 4; 2004Controlled Stimulant Treatment of ADHD and Co-Morbid Tourette's Syndrome: Effects of Stimulant and Dose; by F. Xavier Castellanos, Jay N. Giedd, Josephine Elia, Wendy L. Marsh, Gail F. Ritchie, Susan D. Hamburger, Judith L. Rapoport; Journal Amer Acad Child Adolescent Psychiatry, Vol 36 No 5; 1997Medications; a booklet designed to help mental Health patients and their families; by Dept. of Health and Human Services, NIMHLong Term Safety of Mehtylphenidate in the Treatment of ADHD: Dispelling the Myths and Misconceptions About Stimulant Therapy Abuse; Journal of Clinical Psychiatry Vol 64 Supplement 11; 2003Medications for Children and Adults with FASD, by Teresa Kellerman. FAS Community Resource Centre (2004). USEFUL LINKSMedi-Mouse Drug Search DataBase - Using Health Canada Drug DataBase and BC Pharmacare Drug Master File
